Objectives: To characterize a highly divergent IMP-type metallo-b-lactamase (MBL) variant detected in a multidrug-resistant Pseudomonas aeruginosa clinical isolate.
Introduction
Ambler class B metallo-b-lactamases (MBLs) constitute a growing family of acquired carbapenemases within Pseudomonas aeruginosa strains. 1 The most commonly identified enzymes in P. aeruginosa belong to the IMP and VIM types, while other types, such as NDM, AIM, GIM and SPM, have only been infrequently detected in some geographic regions.
1,2 IMP-type MBLs were the first acquired carbapenemases identified in P. aeruginosa. 3 They are most common in south-east Asian regions and have been occasionally detected in many other regions worldwide, 4, 5 while in Europe there are sporadic reports from Italy, Portugal and central European countries, such as France, the Czech Republic, Slovakia and Austria (http://www. lahey.org/studies). 3,5 -7 IMP-type b-lactamases hydrolyse efficiently and confer resistance to most b-lactam antibiotics, including carbapenems, except aztreonam. 8 They usually consist of 246 amino acid residues and, to date, 42 IMP-type variants have been assigned (http://www.lahey.org/studies), which differ from each other by 1 -54 amino acid residues and exhibit important structural differences. 3 Most bla IMP genes are carried as gene cassettes in class 1 integrons also harbouring other resistance genes, such as aac, aad or bla OXA , within plasmid-or chromosome-borne integron/transposon structures. 3 In the present report, we document the identification and the genetic environment of a highly divergent bla IMP-type variant in a P. aeruginosa clinical isolate of the international clonal complex CC235.
Materials and methods

Bacterial isolates and phenotypic testing
The carbapenem-resistant P. aeruginosa isolate 1876 was recovered in 2005 from an anal screening swab of an immunocompromised patient admitted to a German hospital in the Dutch-German border region (Euregio). As this P. aeruginosa isolate was exceptionally resistant to antibiotics, further molecular analysis of the strain was initiated. Due to current collaboration on antimicrobial resistance in Europe, the isolate 1876 was sent to the expert centre for multidrug resistance in P. aeruginosa at the University of Athens, Greece. Identification and initial susceptibility testing was performed using the Vitek2 system (bioMérieux, Marcy l'Étoile, France). Phenotypic screening for carbapenemase production was performed using the Etest MBL (bioMérieux). MICs of carbapenems and other anti-pseudomonal antibiotics were determined by agar dilution. 9 P. aeruginosa ATCC 27853 was used as a control strain in susceptibility assays.
PCR assays and DNA sequencing
Whole cell DNA from the P. aeruginosa isolate was used as a template in PCR assays. PCRs with primers amplifying MBL, KPC and OXA-48-like genes were used to detect carbapenemase genes. 10 PCRs were also used to detect plasmid-mediated AmpCs in single PCRs for each gene and extended-spectrum b-lactamases (ESBLs), including SHV, PER, TEM, CTX-M and IBC/GES enzymes.
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Integron mapping was performed using a series of successive primers for conserved 5 ′ -CS and 3 ′ -CS sequences combined with primers for MBL genes and aacA6, dfr, aadA, bla OXA-10 , qacED1 and sul genes. 10 -14 Subsequently, as published primers failed to anneal to the 3 ′ -end of the new bla IMP variant, we designed a forward primer, bla IMP-F1 (5 ′ -CTGCCGCCG GAGAGTCTTTG-3 ′ ), annealing to an internal bla IMP fragment, combined with a reverse attC primer (5 ′ -CATATGCGGCAAATGTTTTCAT-3 ′ ), in order to amplify and sequence overlapping products that include the total bla IMP variant. PCR products were purified using a Qiaquick gel extraction kit (Qiagen, Chatsworth, CA, USA) and sequenced on both strands with an ABI Prism 377 DNA sequencer (Applied Biosystems, Foster City, CA, USA).
Multilocus sequence typing (MLST)
Typing of the P. aeruginosa isolate 1876 was performed using MLST according to instructions on the P. aeruginosa MLST web site (http:// pubmlst.org/paeruginosa/). By this scheme, internal fragments of seven housekeeping genes (acsA, aroE, guaA, mutL, nuoD, ppsA and trpE) were amplified and sequenced in duplicate. To determine the CC to which the isolate belongs, eBURST analysis was performed using the eBURST software program (http://eburst.mlst.net/).
Phylogenetic analysis
The amino acid sequences of 31 publicly available IMP-type proteins were retrieved from GenBank. Signal peptides were predicted using the SignalP 4.0. server 15 and were removed prior to alignment. All amino acid sequences were aligned with ClustalW. The phylogenetic tree was constructed using the neighbour-joining method with 1000-times bootstrapping in MEGA5 software. The evolutionary distances were computed using the Dayhoff matrix-based method.
Gene transfer experiments
Attempts to transfer imipenem resistance were initially performed by filter mating experiments using recipient strains of Escherichia coli [26R793 (Lac 2 Rif r )] and P. aeruginosa [PU21 (Rif r )] and selection of transconjugants on Mueller-Hinton agar containing 4 mg/L imipenem and 400 mg/L rifampicin. Transfer of imipenem resistance was subsequently attempted by a shotgun cloning approach after ligating BamHI-digested genomic fragments derived from the investigated P. aeruginosa isolate into plasmid pUCP20 followed by electroporation into P. aeruginosa PAO1.
Nucleotide sequence accession number
The GenBank accession number of the nucleotide sequence reported here is JF816544.
Results
Susceptibility testing
Performance of the Etest MBL suggested that P. aeruginosa 1876 produced a metallo-carbapenemase. The isolate was resistant to imipenem and meropenem (MICs .128 mg/L) and also to amikacin, cefepime, ceftazidime, ciprofloxacin and gentamicin, but susceptible to aztreonam, piperacillin/tazobactam and colistin.
PCR assays for b-lactamase genes and integron structure PCR for the bla IMP gene using the consensus primer pair 14 was repeatedly positive for the bla IMP gene (PCR product of 587 bp). Sequencing of the entire open reading frame of bla IMP revealed a new variant gene, bla . No other carbapenemase, ESBL or plasmidic AmpC-like genes were identified.
The P. aeruginosa isolate was further tested by PCR to investigate the association of the bla IMP-35 gene with a class 1 integron. PCR mapping with combinations of primers for the amplification of the variable region showed that the bla IMP gene was carried in a class 1 integron. Sequencing of the amplicons encompassing the variable region of the integron showed that the isolate carried the bla IMP-35 variant as the first gene cassette, followed by bla OXA-35 and aacA6 gene cassettes (Figure 1a) . A typical 5 ′ -CS containing an intI1 gene with a weak P1 promoter followed directly by inactive P2 promoter (without a GGG insertion prior to the 210 hexamer) and an attI1 site was identified. The last gene cassette of the variable region was followed by a qacED1 allele, typical of the 3 ′ -CS of sul1-associated class 1 integrons. The bla IMP-35 gene was not transferable by conjugation and electroporation.
MLST analysis
The study isolate expressed the allelic profile of ST622, which was also recently detected in Germany. 16 eBURST analysis of ST622 together with other profiles of the P. aeruginosa MLST database showed that ST622 is a single locus variant (SLV) belonging to the clonal complex CC235, which includes 22 SLVs ( Figure S1 , available as Supplementary data at JAC Online). 
Amino acid alignment
Phylogenetic analysis
To compare 31 publicly available IMP protein sequences, a phylogenetic tree was constructed by analysis of their amino acid sequences, further emphasizing the divergence of IMP-35 from the other IMP-type MBLs (Figure 2) . Based on the phylogenetic tree and the amino acid sequence homology, the previously deposited IMP variants were divided into seven clusters, namely the IMP-1 (also including IMP- members of the existing IMP groups, IMP-35 is clearly different, being phylogenetically distant from the remaining variants, with which it shares only 80% -86.6% identity (33 -50 amino acid differences), and forms an eighth separate group that contains solely IMP-35 (Figure 2 ). Phylogenetically the most proximal group is the one consisting of IMP-12, probably reflecting an early divergence of an ancestor gene leading to IMP-12 and IMP-35, which differ, however, at the amino acid level by as much as 13.4%. IMP_3   IMP_6   IMP_1   IMP_10   IMP_4   IMP_30   IMP_38   IMP_15   IMP_28   IMP_5   IMP_7   IMP_9   IMP_25   IMP_29   IMP_16   IMP_22   IMP_11   IMP_21   IMP_12   IMP_35   IMP_14   IMP_18   IMP_27   IMP_13   IMP_33   IMP_24   IMP_8   IMP_19   IMP_20 IMP_2 Figure 2 . Phylogenetic analysis of IMP-type MBLs. Amino acid sequences were aligned with ClustalW and the tree was constructed using the neighbour-joining method. The phylogenetic distances were computed using the Dayhoff matrix-based method. Phylogenetic analysis was conducted using MEGA5. 3,5 -7 The members of the IMP family are grouped in eight distinct clusters of enzymes, indicating that they emerged on several independent occasions in the bacterial environment and possibly suggesting their wide distribution. In this study, we report on the detection of a highly divergent enzyme, , that exhibits at least 13.4% amino acid differences with the closest IMP variants and forms a separate group in the IMP phylogenetic tree, indicating its independent evolution.
Most of the bla IMP gene variants are carried on mobile gene cassettes inserted into class 1 integrons. 3, 4 The class 1 integron array carrying bla IMP-35 , also containing bla OXA-35 and aacA6 genes, has not been identified previously among IMP carriers, further supporting a different phylogeny and underlining the heterogeneity and complexity of IMP-encoding integrons. It should be noted that up to now multiple different class 1 integrons have been reported to carry bla IMP genes, which usually coexisted with aminoglycoside resistance or bla OXA genes, similar with our observation. 3 Also, the carriage of bla IMP-35 as the first gene cassette in this class 1 integron indicates its recent acquisition, as gene cassettes regularly integrate at the front of the array. The bla IMP-35 integration might be driven by exposure to b-lactam or aminoglycoside antibiotics, which is common in hospitalized patients. The ongoing spread of multidrug-resistant bacteria carrying new MBL genes underlines the importance of close monitoring and elucidation of their evolution.
In Germany, P. aeruginosa have been occasionally reported to carry MBLs, mainly of the VIM and GIM types, 5 while uncharacterized IMP-producing Gram-negative bacilli from Germany have been used in a methodological study for the detection of resistance genes. 17 IMP-35 was found in an isolate that belongs to ST622. This type was also identified recently in Germany 16 and is an SLV of the worldwide prevalent international clonal complex CC235, which currently includes 22 SLVs and overall contains 29 STs. 18 Among European countries, CC235 is frequently detected in Mediterranean countries. Also, CC235 was the most common lineage carrying IMP-type genes in east Asian countries such as Japan and Korea. 19, 20 This may imply a propensity of IMP-type genes to be harboured in CC235 isolates and a potential of these genes to spread through the expansion of this successful clone. In conclusion, our findings indicate that IMP-producing CC235 P. aeruginosa strains have also emerged in German hospitals. Epidemiological surveillance in the major healthcare institutions, rational use of carbapenems and adjustment of the infection control measures should be considered to prevent the dissemination of IMP MBL-producing P. aeruginosa within the country and across the border.
